Anzeige
Mehr »
Login
Dienstag, 23.04.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Breaking News: InnoCan startet in eine neue Ära – FDA Zulassung!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
450 Leser
Artikel bewerten:
(2)

Nagarro partners with BioT to deliver best-in-class software for medical devices

DUBAI, UAE, Nov. 24, 2021 /PRNewswire/ -- Nagarro, a global digital engineering company, and BioT Medical, a No-code connected-care platform for medical devices, announced a strategic partnership. In an age of data-driven hyper-personalized care, maximizing the medical device potential has never been more critical. The Nagarro BioT partnership represents the best of two worlds, digital engineering excellence, and connected medical device mastery.

Andrei Doibani, Global Head of Life Sciences and Health, Nagarro

This partnership will allow device manufacturers to transform any medical device into a connected care platform within days and build an end-to-end personalized patient care system that is purposefully built for their needs and is fully integrated with the existing caregiver's ecosystem and workflows. Device manufacturers can now benefit from a direct-to-consumer relationship while providing caregivers with better care capabilities using their existing workflows.

"Our partnership with Nagarro will help fuel both companies' continued innovation and growth efforts. Through our regulated connected care, no-code platform, BioT will enable Nagarro to easily and quickly expand their best-in-class digital health offerings to the broader healthcare market. Together we can deliver a new level of value for medical device manufacturers, their patients, and the entire healthcare ecosystem," says Daniel Adler, Co-Founder & CEO at BioT Medical.

"Digital health ecosystems evolve every day, so do connected medical devices and Software as a Medical Device. The future will be for those who understand the value of connected data integrated into their SaaS solutions and creating personalized care experiences. We are very excited by what BioT is doing in the Life Sciences space. Together we represent that vision. We have a long history of developing Life Sciences solutions around the world and look forward to bringing even more complete and integrated solutions with this exciting partnership," added Andrei Doibani, Global Business Unit Head for Life Sciences and Healthcare at Nagarro.

About BioT

BioT is a medical-grade PaaS (Platform-as-a-service) that, for the first time, introduces a no-code approach to the regulated medical device space. It's a game-changing solution to get medical devices on the cloud in a snap using a template-based drag-and-drop approach, without losing precious time or investing huge development efforts and costs. BioT's Triple-C Connect-Collaborate-Care solution enables medical device manufacturers to securely connect devices to a medical-grade cloud, boost personalized engagement and improve health outcomes through collaboration between patients and caregivers, and turn data into actionable insights to improve clinical decision-making and care experiences. For more information, visit www.biot-med.com.

About Nagarro

Nagarro, a global digital engineering leader, helps clients become innovative, digital-first companies and thus, win in their markets. The company is distinguished by its entrepreneurial, agile, and global character, its CARING mindset, and its approach of "Thinking Breakthroughs". Nagarro employs over 10,000 people in 26 countries. For more information, visit www.nagarro.com.

FRA: NA9 (SDAX, ISIN DE000A3H2200, WKN A3H220)

For inquiries, please contact press@nagarro.com

Photo: https://mma.prnewswire.com/media/1695771/Andrei_Doibani_Nagarro.jpg
Photo: https://mma.prnewswire.com/media/1695772/Daniel_Adler_Co_Founder__CEO_BioT.jpg
Logo: https://mma.prnewswire.com/media/844192/Nagarro_Logo.jpg

Daniel Adler, Co-Founder and CEO BioT

Nagarro Logo

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2021 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.